Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Am J Ophthalmol. 2016 Aug 10;170:161–167. doi: 10.1016/j.ajo.2016.08.004

TABLE 2.

Specific Tests Ordered per Scenario by All Responders (N = 11)

Scenario Tests Ordered Average Number of Tests
1 ACE (3), CBC (1), CT chest (1), CXR (8), HLA-B27 (11), Lyme (2), Lysozyme (1), OCT (1), PPD (2), RPR (5), Syphilis ab (10) 4.09
2 A1C (1), ACE (4), ANA (1), B2 microglobulin (4), Bartonella (1), CBC (8), CMP (5), CXR (10), Creatinine (4), ESR (4), FA (4), Fundus photo (1), HIV (1), Lyme (2), Lysozyme (1), MRI brain (1), OCT (3), PPD (2), QuantiFERON (1), RF (1), RPR (5), Syphilis ab (10), UA (6) 7.27
3 ACE (5), ANA (2), CBC (6), CMP (5), CT chest (3), CXR (9), ESR (2), FA (7), ICG (1), Lyme (2), Lysozyme (2), MRI brain (1), OCT (6), PPD (4), QuantiFERON (1), RF (1), RPR (4), Skin biopsy (1), Syphilis ab (11), UA (1), Viral PCR (1) 6.82
4 ACE (5), CBC (2), CMP (2), CT chest (2), CXR (9), ESR (1), FA (5), Fundus photo (1), HLA-A29 (1), HTLV (1), Lyme (4), Lysozyme (1), MRI brain (5), OCT (8), PPD (3), RPR (4), Syphilis ab (11) 5.91
5 ACE (4), ANA (2), ANCA (1), Bartonella (2), CBC (4), CMP (3), CRP (2), CT chest (4), CXR (8), ESR (3), FA (9), Fundus photo (1), HIV (1), HLA-B51 (1), HTLV (1), Lupus ab (1), Lyme (3), Lysozyme (2), OCT (1), PPD (1), QuantiFERON (8), RF (2), RPR (4), Syphilis ab (10), Toxoplasmosis ab (1), West Nile (1), anti-CCP (1), anti-RNP (1), anti-SS (1) 7.55
6 ACE (1), ANA (10), CBC (5), CMP (2), CXR (4), ESR (1), HLA-B27 (2), Lyme (2), Lysozyme (1), OCT (5), PPD (1), RF (2), RPR (1), Syphilis ab (3) 3.64
7 Bartonella (3), CBC (6), CMP (2), CXR (4), Creatinine (1), Fundus photo (2), HIV (1), ICG (1), Liver panel (1), Lyme (1), PPD (4), QuantiFERON (1), RPR (1), Syphilis ab (8), Toxocara ab (1), Toxoplasmosis ab (10) 4.27
8 ACE (2), ANA (1), ANCA (1), CBC (5), CMP (4), CXR (6), ESR (1), FA (2), Fundus photo (2), HIV (3), HLA-B27 (1), HLA-B51 (1), Lyme (2), MRI brain (1), PPD (3), RPR (6), Syphilis ab (10), Toxoplasmosis ab (4), UA (2), Viral PCR (8) 5.91
9 ANA (6), ANCA (11), CBC (6), CMP (4), CRP (4), CXR (6), Creatinine (2), ESR (7), Lyme (2), PPD (2), RF (7), RPR (1), Syphilis ab (8), UA (5), anti-CCP (5) 6.91
10 ACE (3), CBC (7), CMP (4), CT chest (2), CXR (9), ESR (1), FA (5), Fundus photo (1), HTLV (1), Lyme (4), Lysozyme (1), MRI brain (4), OCT (3), PPD (4), RPR (4), Syphilis ab (10), UA (1), Viral PCR (1) 5.91
11 ACE (4), CBC (5), CMP (4), CT chest (2), CXR (6), Creatinine (2), ERG (2), FA (7), Fundus photo (2), GVF (1), HLA-A29 (9), HVF (2), Hepatitis panel (1), ICG (3), Liver panel (1), Lyme (2), Lysozyme (1), OCT (6), RPR (5), Syphilis ab (9), UA (1) 6.82
12 ACE (1), CBC (2), CMP (1), CXR (5), ESR (2), HLA-B27 (8), Lyme (1), PPD (1), RPR (4), Syphilis ab (6) 2.82
13 ACE (2), CXR (7), HLA-B27 (10), Lyme (2), Lysozyme (1), PPD (1), RPR (4), Syphilis ab (8) 3.18

A1C = Hemoglobin A1C; ACE = angiotensin-converting enzyme; ANA = antinuclear ab; ANCA = antineutrophil cytoplasmic ab; anti-CCP = anti–cyclic citrullinated peptide ab; anti-RNP = anti-ribonucleoprotein ab; anti-SS = anti–Sjogren syndrome ab; CBC = complete blood count; CT = computed tomography; CXR = chest radiograph; ESR = erythrocyte sedimentation rate; FA = fluorescein angiography; HTLV = human T-cell lymphotropic virus; ICG = indocyanine green angiography; Lupus ab = lupus anticoagulant; MRI = magnetic resonance imaging; OCT = optical coherence tomography; PCR = polymerase chain reaction; PPD = purified protein derivative test; RF = rheumatoid factor; RPR = test including rapid plasma reagin and venereal disease research laboratory test; Syphilis ab = test including fluorescent treponemal antibody (ab), microhemagglutination assay, and treponema pallidum particle agglutination; Toxocara ab = toxocara IgM or IgG; Toxoplasmosis ab = toxomplasmosis IgM or IgG; UA = urinalysis with microbiology.